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Abstract
BACKGROUND: Ehlers-Danlos syndrome (EDS) type IV is a heritable disorder of connective tissue that is 
mainly associated with vascular maladies such as aneurysms, pseudoaneurysms, and dissections with or without 
spontaneous rupture. Historically, vascular complications in EDS IV have been treated conservatively whenever 
possible, due to the high morbidity and mortality after vascular interventions, whether open or endovascular. We 
present a case of a ruptured pseudoaneurysm of the right common iliac artery in a 18-year-old male, who was 
successfully treated by endovascular approach and later diagnosed with EDS type IV.
CASE PRESENTATION: A 18-year-old male patient was admitted in ER with sharp pain in the right hypogastrium, 
hypotensive and with reduced blood parameters. Multiphasic modern computed tomography (MDCT) scan of abdomen 
and pelvis revealed massive ride sided pelvic and retroperitoneal hematoma. The presence of pseudoaneurysms 
on both common iliac arteries (CIA) was detected, with small ulcer on the right side and a focal dissection on the 
left side. An urgent endovascular repair of the ruptured pseudoaneurysm on the right CIA with covered stent was 
performed. Patient’s laboratory parameters and clinical status improved significantly within the next few days.
CONCLUSIONS: Vascular repair in EDS-IV patients carries significant risk and should be indicated very carefully. 
Endovascular treatment for these patients is feasible and should be considered as an alternative to open surgery in 
some challenging cases as this one.
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Background
Ehlers-Danlos syndrome (EDS) is a 
heterogeneous group of heritable disorders of connective 
tissue with many subtypes. Type IV subtype results from 
an autosomal dominant mutation in the COL3A1 gene 
that causes a defect of type III collagen production with 
current prevalence of 1 in 50,000–90,000. Extensive 
bruising, history of vascular maladies (aneurysms, 
pseudoaneurysms, and dissections with or without 
spontaneous rupture), spontaneous intestinal perforation, 
and uterine rupture are ones of the major characteristic 
clinical findings in patients with EDS-IV [2]. The overall 
life expectancy of these patients is dramatically shortened 
with a median life span of 48 years.
A disease-related complication affects 25% 
of them by age 20 and 80% by age 40 [1]. Vascular 
complications very often present emergently secondary 
to vascular rupture and without previous diagnosis of 
the underlying genetic condition.
Historically, vascular disease in EDS-IV has 
been treated conservatively whenever possible, favoring 
surgery as an option in life-threatening situations. The 
reported operative mortality including emergent cases 
ranges from 7% to 41% [3].
We present a case of a ruptured pseudoaneurysm 
of the right common iliac artery in a 18-year-old male, 
who was successfully treated by endovascular approach 
and later diagnosed with EDS type IV.
To the best of our knowledge, so far one case 
of elective endovascular treatment for an iliac artery 
aneurysm in a patient with EDS-IV has been reported 
in the international literature [4].
Case Presentation
A 18-year-old male patient was admitted in ER 
with sharp pain in the right hypogastrium which lasted 
for almost 2 days and it worsened over time. At time 
of admission, he was hypotensive and with reduced 
blood parameters. Physical examinations revealed a 
normal weight youngster, pale skin, and with no evident 
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dysmorphism. No recent trauma or surgeries were 
reported. Family history was significant for maternal 
death after labor due to abdominal hemorrhage.
Multiphasic MDCT scan of abdomen and 
pelvis was performed, which revealed massive ride 
sided pelvic and retroperitoneal hematoma (Figure 1).
On the arterial phase presence of 
pseudoaneurysms on both CIAs was detected, with 
small ulcer on the right side and a focal dissection on 
the left side (Figure 2).
The pseudoaneurysm on the right CIA was 
suspected as a possible target location for the active 
bleeding. In light of this active bleeding and continuous 
drop of RBC, HGB, and HCT as well as hypotension, 
urgent treatment was indicated. Multidisciplinary 
vascular team decided that endovascular treatment 
of the pseudoaneurysm of the right CIA is the least 
invasive and most appropriate approach. After careful 
pre-procedural reviewing of the CT images, we decided 
not to cover the ostium of right internal iliac artery to 
make the procedure as simple as possible.
 Figure 1: Preprocedural CT scan in arterial phase (a) and (b) showing 
massive right sided retroperitoneal and pelvic hematoma
a
b
Figure 2: Axial CT scan in arterial phase (a) small pseudoaneurysm 
of the right CIA with active bleeding and (b) large pseudoaneurysm 
with local dissection of the left CIA
b
a
Figure 3: Catheter directed pigtail angiography (a) early arterial and 
(b) late arterial phases showing active bleeding from right the CIA
a
b
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The intervention was conducted with 
conscious sedation and local anesthesia. Right 
common femoral approach was obtained, and a 7F 
introducer (Radiofocus, Terumo) was placed. Aortoiliac 
angiography with a 5F pigtail catheter placed in the 
distal abdominal aorta was performed and an massive, 
active bleeding from right CIA was confirmed (Figure 3).
An ultra-stiff hybrid guidewire (Advantage 0.035,” 
260cm, Terumo) was crossed in thoracic aorta. After 
a predilatation with 7 × 40 mm, non-compliant balloon 
catheter (Mustang, Boston Scientific), a 9 × 38mm 
balloon expandable stent graft was deployed over the 
pseudoaneurysm (Advanta V12, Getinge group) (Figure 4).
Control angiography showed no residual 
bleeding with complete patency of CIA and IIA. 
Puncture site hemostasis was perfumed with manual 
compression. Patient was discharged from hospital on 
second post-procedural day.
On first post-intervention day patient’s 
laboratory parameters stabilized and his clinical status 
improved significantly within the next few days.
At the follow-up CT angiography, 5 weeks after 
treatment there was almost complete resorption of the 
hematoma, with small residual seroma on the right 
side, complete patency of the stent graft, and persistent 
pseudoaneurysm of left CIA (Figure 5).
Since the patient had positive family 
history, was quite young and reported no recent 
trauma or surgeries, a connective tissue disorder 
was suspected. He was further sent for hereditary 
genetic diseases examinations. Subsequently, 
EDS-IV was diagnosed by identification of abnormal 
type III procollagen by fibroblast cell culture and gel 
electrophoresis. The diagnosis was completed by 
identification of a point mutation in the COL3A1 gene 
(c.1662+1G>A).
Figure  4:  (a)  Placement  of  balloon  expandable  stent  graft  9   38 
mm (Advanta V12, Getinge) under RM fluoroscopy and (b) contrast 
aortoiliac  angiography  showing  good  position  of  stent  graft  with 
complete resolution of bleeding
b
a
Figure 5: Control CT angiography 1 month later (a) and (b) showing 
excellent  stent  patency  with  almost  complete  resolution  of  the 
retroperitoneal hematoma and (c) VR reconstruction confirms good 
stent position with persistent pseudoaneurysm of the left CIA
a
b
c
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Conclusions
Vascular repair, whether open or endovascular 
on EDS-IV patients carries significant risk and should 
be indicated very carefully. In a 30-year experience with 
an EDS-IV cohort of 31 patients from the Mayo Clinic, 
70% of vascular operations were performed for urgent 
indications. Major bleeding complications occurred with 
37% of interventions, and 10% of patients died as a 
direct result of hemorrhage [3]. Other series report even 
higher operative mortalities of 19% and 41%. [1,5].
In the general population, the presence of an 
iliac aneurysm portends a high risk of rupture; therefore, 
elective repair above a threshold of 3 cm is advocated. 
Both open and endovascular repair of iliac aneurysms 
can be accomplished with reasonably low morbidity and 
mortality [6]. A higher threshold for any vascular surgery 
in the EDS-IV population has been advocated.
A report of patients treated electively at Johns 
Hopkins Hospital from 1994 to 2009 reveals a great success, 
giving a strong reason to consider elective intervention in 
patients with EDS IV, before rupture happens [2].
The traditional recommendations when 
dealing with vascular complications of EDS-IV favor 
conservative approach, with operative treatment being 
reserved for patients presenting with imminent or frank 
life-threatening bleeding. However, interventionalists 
and surgeons are occasionally faced with the dilemma 
of whether the elective repair of a large asymptomatic 
aneurysm is indicated or should be reserved only 
for urgent cases like this one. Decision-making can 
be difficult because EDS-IV patients have a very 
heterogeneous spectrum of disease.
There are more than 400 mutations identified 
in the COL3A1 gene resulting in EDS-IV and the 
penetrance is nearly 100%, still the phenotypic 
expression varies in severity [1,2].
Our patient’s iliac pseudoaneurysm was 
successfully treated endovascularly with a covered stent. In 
the Mayo series, no patient was treated with endovascular 
techniques other than coil embolization [3]. There have 
been only few cases with endovascular approach in 
EDS-IV patients reported, one is an elective case of non-
ruptured iliac aneurysm treated with EVAR [4], and the 
other is a case of covered stent treatment for a hepatic 
artery aneurysm in EDS-IV patient [7].
Despite the technical and clinical success in this 
single case, taking into consideration that our patient was 
treated emergently without a diagnosis of the underlying 
genetic condition, we urge caution before proceeding 
with endovascular repair in EDS-IV patients. The risk of 
remote vessel dissection and access-site complications 
may be significant and difficult to manage.
Several aspects of this case are worth to 
mention. First, the treatment was necessary to be carried 
out urgently because of active bleeding. Second, the 
position and size of the pseudoaneurysm allowed using 
only one covered stent with specific size which was 
sufficient for a successful completion of treatment and 
preserving the IIA. Other endovascular options were also 
discussed and this one chosen as a most appropriate one 
regarding the size and shape of the pseudoaneurysm.
Ultimately, patient risk-to benefit assessment 
compels any decision to proceed with the type of treatment.
Endovascular treatment for EDS-IV patients is 
feasible and should be considered as an alternative to 
open surgery in some challenging cases as this one.
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